The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report
Open accessAbstract
Objective—: Inflammasomes are multiprotein complexes, and their activation has been associated with cardiovascular disease. Inflammasome activation leads to secretion of caspase-1 by innate immune cells, resulting in the activation of interleukin-1β. Recently, a potent and selective inhibitor of the NLRP3 inflammasome, MCC950, was described. In this study, we investigated the effect of MCC950 on atherosclerotic lesion development in apoE −/− mice. Approach and Results—: First, we determined the efficacy of MCC950 in vitro. Bone marrow–derived macrophages and dendritic cells were stimulated with lipopolysaccharide and cholesterol crystals resulting in high levels of interleukin-1β release, which was inhibited by MCC950. In vivo MCC950 treatment reduced lipopolysaccharide–induced interleukin-1β secretion, without affecting the tumor necrosis factor-α response. Subsequently, atherosclerotic plaques were induced in Western-type diet fed apoE −/− mice by semiconstrictive perivascular collar placement at the carotid arteries, after which the mice received MCC950 (10 mg/kg) or vehicle control 3× per week intraperitoneally for 4 weeks. After euthanize, atherosclerotic plaque size and volume were quantified in hematoxylin-eosin–stained 10-µm cryosections throughout the artery. MCC950 treatment significantly reduced the development of atherosclerotic lesions as determined by maximal stenosis, average plaque size, and plaque volume. Although the amount of collagen and the necrotic core size were not affected, the number of macrophages in the plaque was significantly reduced on treatment. In addition, VCAM-1 (vascular cell adhesion molecule 1) and ICAM-1 (intercellular adhesion molecule 1) mRNA expression was significantly reduced in the carotids of MCC950-treated mice. Conclusions—: These findings show that specific inhibition of the NLRP3 inflammasome using MCC950 can be a promising therapeutic approach to inhibit atherosclerotic lesion development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a mouse model of atherosclerosis, the inhibition of the NLRP3 inflammasome by MCC950 resulted in a significant reduction in atherosclerotic lesions [82].”
From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [82]
In the citing paper
“Inhibition of the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome (NLRP3) suppressed T-cell senescence57 and atherosclerosis.58”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [58]
In the citing paper
“Human atherosclerotic lesions show increased expression of the major components of NLRP3 (REF 61), and inhibition of the NLRP3 inflammasome reduces atherosclerosis in Apoe−/− mice62.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature reviews. Immunology · doi:10.1038/nri2725 · Cited by 1,859
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
The inflammasome: an integrated view
Gross, O., Thomas, C. J., Guarda, G., & Tschopp, J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01046.x · Cited by 778
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R., Dinarello, C. A., & Apte, R. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102048 · Cited by 546
Cited by
Sorted by citations
Items 301–348 of 348
Delfos, L., Huis, C., Imani, N., van Lennep, J. E. R., Hooijmans, C. R., & Bot, I. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178336 · Cited by 2
Self-citationZhang, X., Cheng, L., Ma, X., Ma, K., Xie, J., Gui, W., Chen, J., Liu, K., & Ma, R. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07536-6 · Cited by 3
High-cholesterol-load-triggered pyroptosis of gingival fibroblasts promotes periodontitis
Wang, Z., Li, Y., Chen, H., Zhang, X., Zhang, Y., Gao, X., Luo, J., Song, J., & Zhou, Z. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116259 · Cited by 2
Zheng, Z., Liao, Y., Jiang, Y., Jia, Z., Lin, W., Xu, D., Jin, Y., Zhao, Q., Wu, G., Ye, B., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70419 · Cited by 2
Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers
Liu, A., Chen, H., Liu, Q. Y., Al-Azab, M., Shaher, F., Li, J., Liu, T., & Yang, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1815269 · Cited by 3
Targeting Inflammation in Atherosclerotic Cardiovascular Disease: Mechanisms and Emerging Therapies
Spindler, M. P., Libby, P., & Ridker, P. M. (2026) · Immunological Reviews · doi:10.1111/imr.70151 · Cited by 3
The Changing Face of Atherosclerosis
Meiliana, A., & Wijaya, A. (2023) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v15i3.2347 · Cited by 2
Peran Penting Inflamasom NLRP3 pada Aterosklerosis
Sukmawati, D. (2023) · Jurnal Penyakit Dalam Indonesia · doi:10.7454/jpdi.v10i2.1417 · Cited by 2
Wang, Y., Wu, Y., Ren, J., Wang, Y., Perwaiz, I., Su, H., Li, J., & Qu, P. (2024) · Clinical and Experimental Nephrology · doi:10.1007/s10157-024-02567-7 · Cited by 2
The changes of NLRs family members in the brain of AD mouse model and AD patients
Li, Z., He, Y., Zhang, J., Yang, J. H., Cheng, J., & Zhang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1555124 · Cited by 3
Haque, S. E., Khan, A. G., & Iqubal, A. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223941124010007 · Cited by 2
Borukaeva, I. K., Edilov, K. G., Dzueva, A. S., Labazanova, M. I., & Gidizov, K.-A. R. (2025) · Kazan medical journal · doi:10.17816/kmj646818 · Cited by 1
Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative Drugs
Zudeh, G., Sossai, S., Angelini, J., Stocco, G., & Lucafò, M. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl39537 · Cited by 1
Tian, D., Liu, L. H., Zeng, G.-G., He, J., Liu, H., Ma, D., Yang, Z., Ma, X., Cao, Y., & Xu, C. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm44518 · Cited by 1
Development of immune-derived molecular markers for coronary heart disease via multimachine learning
Wang, H., Du, C., Yang, T., Wang, W., Zhou, L., Gu, L., Wang, S., Gao, W., 严建军, Wang, L., et al. (2026) · iScience · doi:10.1016/j.isci.2026.114853 · Cited by 1
Silva‐Velasco, D. L., dos Passos, R. R., Moraes, R. A., Gonçalves, T. T., Wilczynski, S., Zhang, T., Randar, S., Tobin, J. K., Uline, M. J., Priviero, F. B. M., et al. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_802 · Cited by 1
Xu, C., Ke, C., Zhong, Y.-L., Yang, X.-H., Wang, M.-M., Cao, Y., & Chen, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103225 · Cited by 1
Macrophage CCRL2 promotes NLRP3 inflammasome activation to exacerbate atherosclerosis
Cai, Q., Duan, Z., Yang, Z., Luo, Y., Liu, M., Wu, C., Wang, T., Wang, Y., Liang, L., Liu, Q., et al. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01450-7 · Cited by 1
McGilligan, V. (2019) · Online Journal of Cardiology Research & Reports · doi:10.33552/ojcrr.2019.03.000556 · Cited by 1
Endothelial Dysfunction in Type 2 Diabetes with an Update on New Interventions
Ward, N. C., Loh, W. J., & Watts, G. F. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_14 · Cited by 2
ApoE-Knockout Mice: What are New Achievements of this Model of Atherosclerosis?
Lorkowska-Zawicka, B., & Jawień, J. (2021) · Acta Scientific Pharmaceutical Sciences · doi:10.31080/asps.2021.05.0737
Shen, J., Yang, D., Chen, M. Y., & Guo, X. (2021) · PubMed Central · doi:10.19723/j.issn.1671-167x.2021.03.001 · Cited by 1
Qi, Z., Liu, X., Zhao, G., & Ge, J. (2022) · Cardiology Plus · doi:10.1097/cp9.0000000000000018 · Cited by 1
Kosma, J. (1945) · DigitalCommons (California Polytechnic State University) · Cited by 1
Pereira, C. A. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-08112018-150821
The NLRP3 inflammasome pathway in autoimmune diseases: a chronotherapeutic perspective?
Bellengier, C., Duez, H., & Pourcet, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824390-9.00006-2
Endothelial Shear Stress and Atherosclerosis: From Mechanisms to TherapeuticsPreprint
He, L., Zhang, C., Chen, Q., Wang, L., & Huang, Y. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3975295
Role of CCs and Their Lipoprotein Precursors in NLRP3 and IL-1β Activation
Rajamäki, K., & Öörni, K. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-41192-2_15
Role of Kupffer cells and other immune cells
Puengel, T., & Tacke, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00024-3
Li, Z., Ju, J., Jia, X., Peng, X., Zhang, A.-Q., Wang, J., & Gao, F. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.09.001
Owona, B. A., Ndam, V. N., Tchamba, J. C. T., Njayou, F. N., & Moundipa, P. F. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01628-4
Yasuda, T. (2025) · World Journal of Orthopedics · doi:10.5312/wjo.v16.i10.108992
Su, Z.-D.-Z., Li, C.-Q., Wang, H.-W., Zheng, M.-M., & Chen, Q.-W. (2024) · Figshare · doi:10.6084/m9.figshare.26600992
Su, Z.-D.-Z., Li, C.-Q., Wang, H.-W., Zheng, M.-M., & Chen, Q.-W. (2024) · Figshare · doi:10.6084/m9.figshare.26600998
Su, Z.-D.-Z., Li, C.-Q., Wang, H.-W., Zheng, M.-M., & Chen, Q.-W. (2024) · Figshare · doi:10.6084/m9.figshare.26600995
Su, Z.-D.-Z., Li, C.-Q., Wang, H.-W., Zheng, M.-M., & Chen, Q.-W. (2024) · Figshare · doi:10.6084/m9.figshare.26601001
Cellular immunology of preterm labor and birth and its potential utility for biomarker discovery
Gomez‐Lopez, N., Levenson, D., Lee, S., Neshek, B., & Galaz, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21564-3.00020-9
Assrawi, E. (2019) · theses.fr (ABES) · doi:10.70675/82f530d5z0154z474cz9746z470b6a42c9e0
OxLDL-induced ferroptosis and pyroptosis in atherosclerosis: a mini review
Liu, S., Wu, Y., Chen, L., Hu, L., & Yin, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1831457 · Cited by 1
Jin, Y. H., Xu, L., Xiong, Y., Sun, D., Liu, L., Lu, X., Yuan, Y., Yang, N., Ren, Z., Lu, D., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323765
Karnewar, S., Nguyen, T. A., Ozawa, K., Huang, W., Varli, O., Morello, M., Lindner, E. L., Casarez, E. V., Xie, A., López, J. A., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.121848
Mardi, A., Ahmadi, H., Abdolmohammadi‐Vahid, S., Zahmatkesh, P., Savari, G., Soltani‐Zangbar, M. S., & Maleki, L. A. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02221-8
Yu, X., Cui, C., He, J., Guan, X., & Zhang, Z. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1805737
Therapeutic Potential of NLRP3 Inhibitor MCC950 in Aging Mice Stroke Outcomes
Kamat, P. K., Khan, M. B., Siddiqui, S., Dua, A., Divekar, S., David, H., Hussain, M. A., Gavankar, S., & Hess, D. C. (2026) · Translational Stroke Research · doi:10.1007/s12975-026-01491-0
Shen, Q., Fan, Z., Hou, J., Li, F., Wang, Y., Liu, Z., Jiang, C., & Dong, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1918938
Baek, S., Kang, M. S., Raffa, G. M., Pisano, C., Nuzzi, V., Kowalewski, M., Suwalski, P., & Urbanowicz, T. K. (2026) · Antioxidants · doi:10.3390/antiox15101222
Liang, L.-K., Ye, Q., Li, J., Shi, L.-Y., Wang, S.-P., Liang, W.-J., Chen, A., & Feng, G. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01947-x
Metadata
- Authors
- van der Heijden, T., Kritikou, E., Venema, W., van Duijn, J., van Santbrink, P. J., Slütter, B., Foks, A. C., Bot, I., & Kuiper, J.
- Affiliations
- From the Cluster BioTherapeutics, LACDR, Leiden University, The Netherlands.
- Leiden University (NL)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2017-08
- Volume
- 37
- Issue
- 8
- Pages
- 1457-1461
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2623847043
- Cited by
- 348
- References
- 21
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 35 · 2023: 49 · 2022: 47 · 2021: 66 · 2020: 40 · 2019: 29 · 2018: 24 · 2017: 4
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission
- ZonMw
- Servier
- Nederlandse Federatie van Universitair Medische Centra
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- NLRP3 inflammasome, MCC950, atherosclerosis, atherosclerotic plaque, ApoE-deficient mice, IL-1β, caspase-1, macrophages, dendritic cells, VCAM-1, ICAM-1, carotid artery stenosis, anti-inflammatory therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Anti-Inflammatory Agents, Apolipoproteins E, Carotid Arteries, Carotid Artery Diseases, Cells, Cultured, Cholesterol, Crystallization, Dendritic Cells, Disease Models, Animal, Female, Furans, Heterocyclic Compounds, 4 or More Rings, Indenes, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Necrosis, Phenotype, RNA, Messenger, Sulfonamides, Sulfones, Time Factors, Signal Transduction, Mice, Knockout, Intercellular Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, Genetic Predisposition to Disease, Atherosclerosis, Interleukin-1beta, Plaque, Atherosclerotic, Inflammasomes, Diet, Western
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
